About
Paula Soteropoulos is the Chairman of the Board of Ensoma. She is a former Founding CEO at Akcea Therapeutics. Paula is a global strategic and operating management executive with over 20 years of success at building high-performance global teams, leading complex development programs from early stage through approval, and launching global products. Prior to joining Moderna, Paula was the Vice President and General Manager of Genzyme’s Global Cardiovascular business. She was responsible for the development and commercialization of multiple therapeutics across Renal, Transplant & Oncology, Rare Disease, and Cardiovascular. During her tenure at Genzyme, she was instrumental in advancing new compounds from discovery through clinical development and commercialization with significant roles driving product strategy, portfolio, program and alliance management, sales and marketing and business development. Additionally, Paula led strategic manufacturing capacity planning, supply chain develo
Position in the VCSift Database
- • 75 investors hold the Chairman of the Board role in VCSift. Paula Soteropoulos is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
Find more investors like Paula
Search Investors